London Daily

Focus on the big picture.
Wednesday, Apr 01, 2026

‘Ground zero of the opioid epidemic’: West Virginia puts drug giants on trial

‘Ground zero of the opioid epidemic’: West Virginia puts drug giants on trial

A series of federal cases over the pharmaceutical industry’s push to sell narcotic painkillers which created the worst drug epidemic in US history
The trial of the three biggest US drug distributors for illegally flooding West Virginia with hundreds of millions of prescription opioid pills, and driving the highest overdose rate in the country, is due to open on Monday.

The city of Huntington and surrounding Cabell county are suing McKesson, AmerisourceBergen and Cardinal Health, among the largest corporations in the US, as part of a series of federal cases over the pharmaceutical industry’s push to sell narcotic painkillers which created the worst drug epidemic in American history.

The two West Virginia local authorities accuse the distributors of turning Cabell county, with a population of just 90,000, into the “ground zero of the opioid epidemic sweeping the nation”, by flooding the area with nearly 100m opioid pills over a decade.

The lawsuit claims the companies put profit before lives by working in concert with “pill mill” doctors and pharmacists who were little better than drug dealers in supplying opioids to anyone who paid, in breach of laws requiring distributors to halt and report suspicious sales.

“The wholesale distributors have wholly ignored their legal obligations,” lawyers for Cabell county said.

“Instead of implementing controls to stop opioid abuse and alerting authorities to suspicious orders, the distributors have chosen to abuse their privileged position, lining their pockets by shipping massive quantities of drugs to distributors, pharmacies, and dispensaries without performing any checks – with devastating consequences to Americans.”

The companies say they were doing no more than delivering legal drugs to licensed pharmacies to fill prescriptions written by doctors.

If the trial goes ahead on Monday, it will be the first in a series of bellwether cases to establish whether opioid makers, distributors and pharmacy chains are liable to pay out billions of dollars to thousands of counties, cities and Native American tribes harmed by an epidemic that has caused more than 500,000 deaths since 1999 and blighted the lives of millions more.

In October 2019, McKesson and AmerisourceBergen were among four companies that agreed to pay $260m to settle another case hours before a trial was to begin in Ohio, threatening to expose what the distributors knew about illegal sales of the opioids they were delivering to fill prescriptions written by doctors and dispensed by pharmacists who have since been imprisoned.

In the West Virginia case, the distributors are seeking to prevent testimony by witnesses including West Virginia’s former chief health officer, Dr Rahul Gupta.

Defence lawyers want to block Gupta speaking about whether the pharmaceutical industry’s push to sell opioids led to overdose deaths, and whether addiction to prescription opioids drew people into using illegal narcotics such heroin and fentanyl which are not the main cause of overdoses.

The companies also do not want Gupta to speak about the epidemic’s impact on social issues such as the number of children taken into foster care.

Opioid distributors have paid out hundreds of millions of dollars to settle federal accusations that they failed to meet legal obligations to halt suspicious opioid deliveries, including McKesson which paid a record $150m fine in 2017.

Joseph Rannazzisi, a former senior Drug Enforcement Administration official who took action against the distributors, has called them “criminals” and said they “lack a conscience”.

The West Virginia lawsuit accuses the distributors of creating a “public nuisance”, a claim successfully used by Oklahoma against Johnson & Johnson over its push to sell opioids in the state using false claims about effectiveness and safety. A judge awarded the state $465m.

Drug distributors delivered 1.1bn opioid pills to West Virginia between 2006 and 2014, even as the state’s overdose rate rose to the highest in the US. Nearly 9m pills went to a single pharmacy in the small town of Kermit, with a population of 350, over just two years.

In 2018, the heads of the three drug distributors were lambasted at a congressional hearing by both Democrats and Republicans after denying their companies played any part in the opioid epidemic.

David McKinley, a Republican representing a West Virginia district, accused the CEOs of feeding the epidemic by riding roughshod over the law.

“None of you was complying with state law,” he said. “And yet you say, ‘We weren’t responsible.’ I think you were very much responsible.”

McKinley asked why, if doctors and pharmacists have gone to prison, drug distributor executives should not be jailed too.

“I just want you to feel shame about your roles, respectively, in all of this,” he said.
Newsletter

Related Articles

0:00
0:00
Close
King Charles Plans US State Visit as UK Strengthens Ties with Trump Leadership
UK Regulator Launches Investigation Into Microsoft’s Business Software Practices
Kanye West Set for High-Profile Return to UK Stage at Wireless Festival
Trump Presses Europe to Strengthen Commitment as Iran Conflict Escalates
UK to Deploy Additional Troops to Middle East Amid Rising Regional Tensions
UK Authorities Face Claims of Heavy-Handed Measures in Monitoring Released Pro-Palestine Activists
Trump Calls on UK to Secure Its Own Energy as Iran Conflict Intensifies
Nigel Farage Declines Invitation to UK Conservative Conference Led by Liz Truss
Trump Warns Allies to Take Responsibility as Rift Deepens with UK and France Over Iran Conflict
How Britain’s Prime Minister Controls U.S. Bomber Access in Escalating Iran Conflict
Trump Urges Allies to Secure Their Own Oil Supplies as Hormuz Crisis Disrupts Global Energy
Russia Expels British Diplomat as UK Pushes Back Against Pressure
White House App Faces Scrutiny After Claims of Continuous User Location Tracking
BBC Faces Scrutiny Over Allegations of Paid Content Linked to Saudi Arabia
UK-France Coastal Patrol Agreement Nears Breakdown Amid Migration Pressures
UK Police Detain Pro-Palestine Activist Again Weeks After Bail Release
FTSE 100 Advances as Energy and Mining Shares Gain Amid Middle East Tensions
Eli Lilly Seeks UK Pricing Deal to Unlock Renewed Pharmaceutical Investment
Three Arrested in UK After Massive Cocaine Haul Discovered Hidden in Banana Shipment
UK Fuel Prices Poised for Further Surge Amid Global Energy Pressures
Apple Subsidiary Penalized by UK Authorities for Breach of Moscow Sanctions
Western Allies Intensify Coordinated Sanctions Strategy Against Russia
UK Lawmakers Face Criticism Over Renewed Push for Social Media Restrictions
Starmer Signals UK Crackdown on Addictive Social Media Features
Rising Costs Push One in Five UK Hospitality Businesses to the Brink of Closure
Man Arrested on Suspicion of Attempted Murder After Car Strikes Pedestrians in UK, Injuring Seven
Escalating Conflict Involving Iran Tightens Fiscal Pressures and Highlights UK Economic Vulnerabilities
UK Moves to Confront Russian ‘Shadow Fleet’ Operating in Its Waters
UK Housing Divide Deepens as Older Owners Hold Wealth While Under-30s Face Mounting Barriers
London Demonstration Calls on UK to Recognize Iranian Opposition’s Provisional Government
UK Green Party Vote on ‘Zionism is Racism’ Motion Collapses Amid Internal Disputes and Technical Failures
SNL UK Ignites Debate with Sharp Royal Satire Targeting Prince Andrew and Prince William
EU Proposes ‘Emergency Brake’ to Resolve Deadlock in UK Youth Mobility Talks
Thousands Rally in London to Oppose Rise of Far-Right Movements
Hong Kong Official Rejects Allegations of Surveillance Orders Targeting UK-Based Dissidents
PayPal Expands Cryptocurrency Services to Allow UK Users to Buy and Sell Bitcoin
UK Minister Challenges Reform Party’s ‘Pro-Family’ Agenda as Debate Intensifies
Concerns Grow Over Meningitis Risk Among UK Students Amid Warning Signs of New Outbreaks
Japanese Grand Prix 2026: Schedule, UK Start Times and Full Broadcast Details
Electric Vehicles Seen as Strategic Solution to UK Fuel Reserve Concerns
Rise of Lone-Actor Threats and Online Radicalisation Drives New Wave of Antisemitic Attacks in the UK
Canada Advances Plan to Ban Cryptocurrency Donations in Election Campaigns
UK Faces Looming Medicine Shortages as Iran Conflict Threatens Supply Chains
Deadly Meningitis Outbreak in the U.K. Highlights Urgent Need for Vaccination
Fresh Claims Emerge Over Harry and Meghan’s Australia Visit as Insider Speaks Out
NATO Assessment Indicates UK Defence Spending Has Fallen Below Alliance Average
FTSE 100 Slips as Middle East Tensions Weigh on Investor Sentiment
UK Economy Begins to Feel Early Impact of Iran Conflict as Policy Challenges Intensify
Russian National Jailed in UK After Assault Case Linked to Barron Trump’s Alert
Energy Price Surge Accelerates Shift Away from Fossil Fuels in UK Homes
×